Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Russia has publicly accused the United States and Israel of attempting to pull Arab Gulf countries into a wider regional conflict by provoking Iran into retaliatory strikes. Moscow says Iranian drone and missile attacks have followed air strikes by the United States and Israel and that these attacks have struck oil infrastructure and caused human a…
Goldman Sachs warns that a widening conflict in Iran, which could curtail Middle East oil and gas flows, raises the risk of a temporary oil price surge to $100 per barrel. Under its baseline, the bank expects only modest economic effects, but a jump to $100 would materially increase global inflation and slow growth, with implications for monetary p…
Mark C. Rodgers, Newmont's Managing Director for Africa-Asia Pacific, sold 1,361 shares on March 3, 2026, for $120.78 per share under a pre-established Rule 10b5-1 plan. Following the trade, Rodgers retains 25,756 shares. The sale occurred while Newmont shares traded at $119.37 and as the company is navigating analyst revisions, production forecast…
James S. Abernethy, a director of Peoples Bancorp of North Carolina Inc (PEBK), sold 477 shares on March 3, 2026, for $37.60 per share, netting $17,935. The transaction leaves him with substantial direct and indirect ownership. Separately, the bank announced a $0.17 per share special cash dividend with a February 4, 2026 record date and a February …
Abercrombie & Fitch (ANF) is trading near $96 with strong cash flow, a lean balance sheet and an EV/EBITDA around 4.3. Fundamentals show high ROE (≈39.6%) and free cash flow of $384.5M, implying the stock is priced for modest growth. This trade idea argues for a long position sized prudently, with an entry at $96.00, stop at $85.00 and target at $1…
Berkshire Hathaway looks reasonably priced at roughly $487.50 with a P/E near 15.7, a modest P/B of ~1.5 and a near‑record cash war chest of $373.3B. Given the new leadership under Greg Abel and the company’s diversified earnings streams, a measured long position offers attractive asymmetry. Trade plan: enter at $487.50, target $540.00, stop $455.1…
The U.S. dollar resumed gains Thursday after a brief retreat, supported by renewed geopolitical risk in the Middle East and a jump in oil prices. The Dollar Index traded at 98.897 at 04:35 ET (09:35 GMT), extending its move back toward this week’s three-month peak. U.S. political and military developments, signals of slowing U.S. activity in the Fe…
Senior executives from China’s leading semiconductor firms and institutes published a joint appeal urging the government to coordinate resources and plans to develop complete operational lithography systems between 2026 and 2030. They highlighted existing technical advances in subsystems but said the task of integrating those components into full m…
Three people familiar with policymaker deliberations and market analysts say the U.S. and Israel’s military action against Iran has raised oil prices and disrupted regional gas supplies in ways that are likely to slow India’s economic growth more than push up consumer inflation. That dynamic, they add, makes the Reserve Bank of India (RBI) unlikely…
James S. Abernethy, a director at Peoples Bancorp of North Carolina Inc (NASDAQ: PEBK), sold 477 shares on March 3, 2026, for $37.60 each, totaling $17,935. The stock is trading at $38.41, roughly 50% higher over the past year, while third-party analysis indicates shares may be overvalued versus fair value. The company also announced a special cash…
Mark C. Rodgers, MD, Newmont’s Africa-Asia Pacific executive, sold 1,361 shares on March 3, 2026 for $120.78 each, netting $164,381. The transaction occurred under a Rule 10b5-1 plan and follows a 176% year-over-year rally in Newmont shares. Analysts’ views vary from bullish upgrades to cautious targets as the company navigates production declines,…
Bank Negara Malaysia held its overnight policy rate at 2.75% on Thursday, in line with the unanimous forecast of 27 economists surveyed by LSEG. The central bank's choice reflects subdued headline inflation of 1.6% year-over-year in January and a view that current price dynamics are not an immediate policy concern, even as global energy prices rise…
Boskalis reported a record €1,336 million in EBITDA for fiscal year 2025, a 3% rise year-on-year and a 16% increase when excluding a prior exceptional gain. Revenue grew 2%, driven by Offshore Energy and a sharp improvement in Towage that offset a decline in Dredging & Infra. The company cautioned it does not expect to match the 2025 performance in…
Hunting PLC delivered fiscal 2025 results aligned with prior guidance, including EBITDA that matched expectations, while revealing a marked reduction in its order book. Management kept fiscal 2026 EBITDA guidance unchanged, approved a fresh $40 million share buyback and outlined additional cost cuts even as certain divisional margins softened.
Babcock International reported fiscal 2025 results that modestly outperformed consensus on earnings per share and adjusted EBITA, while matching revenue expectations. The defence-focused engineering group recorded stronger-than-expected free cash flow, expanded its order book and announced a £75 million share buyback that prompted an update to year…
Cicor Technologies reported fiscal 2025 revenue of CHF617m, slightly above analyst projections, but showed margin compression linked to recent acquisitions. Orders and free cash flow outperformed estimates, while the company set sales and EBITDA guidance for fiscal 2026 that anticipates a return to organic growth later in the year.
R&S Group reported second-half fiscal 2025 results that exceeded analyst forecasts for EBITDA, EBIT and net profit, delivered an adjusted full-year EBITDA margin above prior guidance, and reconfirmed its order intake, sales and backlog while maintaining medium-term targets for organic growth and margins.
Honest Company Chief Innovation Officer Stephen Winchell reported the sale of 73,685 shares on March 3, 2026, per a Form 4 filing. The transaction totaled $209,265 at a weighted average price of $2.84. After the sale Winchell directly holds 517,466 shares, including 444,422 restricted stock units. The stock has traded up to $2.93 recently. The comp…
Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International Inc (NYSE: CRL), purchased 25 shares on March 3, 2026, for $174.54 each, a transaction valued at $4,363. The company recently reported fourth-quarter 2025 results that exceeded analyst expectations and disclosed plans to dives…
Catherine T. Doherty, Executive Vice President at Quest Diagnostics (DGX), completed two separate stock disposals on March 2 and March 3, 2026. One sale on March 3 involved 632 shares at $207.73 worth $131,285. A March 2 disposal of 648 shares at $204.86, totaling $132,749, was executed to cover tax obligations tied to vesting restricted share unit…
Verisign Executive Vice President, General Counsel and Secretary Thomas C. Indelicarto sold 498 shares of Verisign stock on March 3, 2026, across two trades that generated $115,426. The filing records his post-sale holdings and recent dividend-equivalent restricted stock units; the company reported mixed fourth-quarter 2025 results and trades at a …
U.S. equity futures fell early Thursday as the conflict involving Iran extended into a sixth day, lifting oil prices and adding to investor uncertainty. Republican senators blocked a congressional measure aimed at limiting President Trump's authority to continue strikes. Energy benchmarks rose sharply, while Broadcom stock jumped after better-than-…
NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, executed a pre-arranged sale of 25,000 shares on December 15, 2025, realizing $399,250. Subsequent withholding of 1,340 vested restricted shares occurred on March 3, 2026 to cover tax obligations. The company reported fourth-quarter 2025 results that beat analyst forecasts on both EPS and reve…
Amy Parison, senior vice president and chief financial officer of Editas Medicine, sold 474 shares of the company’s common stock on March 3, 2026, under a pre-arranged automatic sales plan established in 2022 to meet tax obligations arising from restricted stock units that vested on March 2, 2026. The trade, reported on a Form 4 filing, totaled $95…
Pedro J. Lopez-Baldrich, Chief Legal Officer of SharkNinja, sold 24,099 ordinary shares on March 3, 2026, in multiple transactions under a Rule 10b-5 trading plan. The disposals totaled $2,775,261 at prices between $113.64 and $116.37. SharkNinja is valued at $16.2 billion and recent quarterly results showed adjusted sales growth of 17.6%, with adj…
